In the Boardroom - Merck KGaA

Filter

Current filters:

Merck KGaA

Popular Filters

110 to 134 of 181 results

Merck KGaA 2nd-qtr sales slip, but EBITDA beats forecasts

06-08-2013

German health care and chemicals firm Merck KGaA (MRK: DE) reported second-quarter 2013 financial results,…

FinancialMerck KGaAMerck SeronoPharmaceutical

AstraZeneca in oncology partnerships with University of Cambridge, Cancer Research UK and Blackfield

09-07-2013

Anglo-Swedish drug major AstraZeneca (LSE: AZN) has reached agreement with the University of Cambridge…

AstraZenecaBlackfieldBoehringer IngelheimJanssenMerck KGaAolaparibOncologyPharmaceuticalResearch

Merck Serono sets up new platform for cancer therapies innovation

26-06-2013

Merck Serono, the biopharmaceutical division of Germany's Merck KGaA (MRK: DE) says it has created a…

BiotechnologyImmunologicalsMerck KGaAMerck SeronoOncologyPharmaceuticalResearch

Merck Serono collaborates with China's BeiGene on second-generation BRAF Inhibitor

31-05-2013

Merck Serono, a division of Germany's Merck KGaA (MRK: DE), today (May 31) announced that it has signed…

BeiGeneBeiGene-283BiotechnologyLicensingMerck KGaAMerck SeronoOncologyPharmaceutical

Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux

23-05-2013

Australian drug developer Alchemia (ASX: ACL) and Merck Serono, a subsidiary of Germany's Merck KGaA…

AlchemiaBiotechnologyErbituxHA-IrinotecanMerck KGaAMerck SeronoOncologyPharmaceuticalResearch

Merck KGaA ups commitment to MS Ventures to 100 million euros

16-05-2013

Germany's Merck KGaA says that it will increase its commitment to its strategic corporate venture capital…

BiotechnologyFinancialMerck KGaAMerck SeronoResearch

Merck Serono Ph III trial of L-BLP25 fails endpoint in NSCLC

16-05-2013

Merck Serono, a division of Germany's Merck KGaA (MRK: DE), announced detailed results from the randomized…

BiotechnologyL-BLP25Merck KGaAMerck SeronoOncologyPharmaceuticalResearchStimuvax

Merck Serono and Quintiles enter novel clinical development partnership

16-05-2013

Merck Serono, the biotech division of Germany's Merck KGaA (MRK: DE) and Quintiles (NYSE: Q) have announced…

BiotechnologyMerck KGaAMerck SeronoPharmaceuticalQuintilesResearch

Merck KGaA adjusted 1st-qtr earnings leap 19%, beating forecasts

14-05-2013

Shares of Germany's Merck KGaA out on 1.9% to 124.52 euros this morning (May 14), after the company reported…

FinancialMerck KGaAMerck SeronoPharmaceutical

AEterna Zentaris transfers Cetrotide rights to Merck KGaA

18-04-2013

Canada's AEterna Zentaris (TSX: AEZ) says that its German subsidiary has entered into binding agreements…

AEterna ZentarisCetrotideLicensingMerck KGaAMerck SeronoPharmaceuticalReproductive

Appeals Court rules against EMD Serono over Rebif deal with Pfizer

16-04-2013

Germany's Merck KGaA (MRK: DE) says that a Pennsylvania appeals court has ruled against Merck in deciding…

BiotechnologyEMD SeronoLegalMarkets & MarketingMerck KGaANeurologicalNorth AmericaPfizerPharmaceuticalRebif

Merck Serono's EPP funds EspeRare Foundation, which will reposition rimeporide

15-04-2013

Merck Serono, the biotech unit of Germany's Merck KGaA (MRK: DE) has announced the launch of the EspeRare…

BiotechnologyEspeRare FoundationFinancialMerck KGaAMerck SeronoPharmaceuticalRare diseasesResearchrimeporide

Columbia Labs extends ex-US Crinone accord with Merck Serono into 2020

09-04-2013

USA-based Columbia Laboratories (Nasdaq: CBRX) has amended its license and supply agreement with Merck…

Columbia LaboratoriesCrinoneLicensingMerck KGaAMerck SeronoPharmaceuticalReproductive

AstraZeneca acquires AlphaCore; Merck Serono links with BioMed X

03-04-2013

In line with its stated policy of targeted acquisitions, Anglo-Swedish drug major AstraZeneca (LSE: AZN)…

AlphaCore PharmaAstraZenecaBiotechnologyCardio-vascularMerck KGaAMerck SeronoMergers & AcquisitionsMetabolicsPharmaceuticalResearch

Merck KGaA links with Bristol-Myers for Glucophage promotion in China

19-03-2013

German drugs and chemicals group Merck KGaA this morning announced a collaboration with US pharma major…

Asia-PacificBristol-Myers SquibbDiabetesGlucophageGlucophage XRLicensingMarkets & MarketingMerck KGaAPharmaceutical

Merck Serono collaborates with Nordic Bioscience for sprifermin in osteoarthritis

18-03-2013

German drug and chemical major Merck KGaA (MRK: DE) says its Merck Serono division has entered into a…

Anti-Arthritics/RheumaticsMerck KGaAMerck SeronoNordic BiosciencePharmaceuticalResearchsprifermin

Merck KGaA posts strong sales and earnings growth for 2012

07-03-2013

Germany's Merck KGaA today reported financial results for 2012 showing 8.7% growth in total revenues…

BiotechnologyFinancialMerck KGaAMerck SeronoPharmaceutical

Merck KGaA's glioblastoma candidate cilengitide fails in Ph III study

25-02-2013

German drug major Merck KGaA (MRK: DE) revealed this morning that the Phase III CENTRIC trial of the…

BiotechnologycilengitideMerck KGaAMerck SeronoOncologyPharmaceuticalResearch

Merck Serono to in-license Opexa's MS drug candidate Tcelna

06-02-2013

USA-based Opexa Therapeutics (Nasdaq: OPXA) has entered into an agreement with Merck Serono, a division…

BiotechnologyLicensingMerck KGaAMerck SeronoNeurologicalOpexa TherapeuticsPharmaceuticalTcelna

Merck Serono initiation of TH-302 Ph III trial triggers $30 million milestone for Threshold

29-01-2013

Merck Serono, the pharma division of Germany's Merck KGaA (MRK: DE), has initiated the global Phase III…

FinancialMerck KGaAMerck SeronoOncologyPharmaceuticalResearchTH-302Threshold Pharmaceuticals

US FDA approves Merck KGaA's Rebif Rebidose

04-01-2013

German drug major Merck KGaA's (MRK: DE) US subsidiary EMD Serono and pharma behemoth Pfizer (NYSE: PFE)…

BiotechnologyEMD SeronoMerck KGaANeurologicalNorth AmericaPfizerPharmaceuticalRebifRegulation

110 to 134 of 181 results

Back to top